Press Release: OvaScience : JAGGAER, Science Exchange and OvaScience Cite Supply Chain Digital Transformation as Critical for R&D Efficiency in 2019

RESEARCH TRIANGLE PARK, N.C., Dec. 12, 2018 (GLOBE NEWSWIRE) -- The key to accelerating the R&D process for research-intensive companies, like biopharma, lies in a clear strategy and adoption of technologies for digital transformation, argue Elizabeth Iorns, Ph.D., CEO of Science Exchange, Inc., James Lillie, Ph.D., Chief Scientific Officer at OvaScience, Inc., and Nancy McLaughlin, Director, Professional Services at JAGGAER, on the latest edition of JAGGAER’s InsideSpend webinar series. JAGGAER is the world’s largest independent spend management company, Science Exchange is the leading marketplace for research services, and OvaScience is a publicly traded biotechnology company. This webinar was designed to provide actionable insights for Chief Procurement Officers, VPs, and Directors and Managers of procurement.